Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Psychopharmacology|August 4, 2009
Alterations in tryptophan and purine metabolism in cocaine addiction: a metabolomic studyAshwin A Patkar, Steve Rozen, Paolo Mannelli, et al.
Plos One|September 25, 2008
Frontal white matter anisotropy and antidepressant remission in late-life depressionWarren D Taylor, Maragatha Kuchibhatla, Martha E Payne, et al.
Plos One|November 5, 2010
Variability in frontotemporal brain structure: the importance of recruitment of African Americans in neuroscience researchNneka Isamah, Warachal Faison, Martha E Payne, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 21, 2004
The association between depression and chronic kidney disease and mortality among patients hospitalized with congestive heart failureS Susan Hedayati, Wei Jiang, Christopher M O'Connor, et al.
Journal of Clinical Psychopharmacology|October 25, 2011
Results from 2 randomized, double-blind, placebo-controlled studies of the novel NK1 receptor antagonist casopitant in patients with major depressive disorderEmiliangelo Ratti, Kevin Bellew, Paolo Bettica, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 14, 2005
Comparing the effects of antidepressants: consensus guidelines for evaluating quantitative reviews of antidepressant efficacyJeffery A Lieberman, Joel Greenhouse, Robert M Hamer, et al.
Psychopharmacology Bulletin|June 29, 2010
Effectiveness of a brain-computer interface based programme for the treatment of ADHD: a pilot studyChoon Guan Lim, Tih-Shih Lee, Cuntai Guan, et al.
The Primary Care Companion for CNS Disorders|March 8, 2013
The effectiveness of antidepressant monotherapy in a naturalistic outpatient settingTih-Shih Lee, Pryseley Nkouibert Assam, Kenneth R Gersing, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|June 26, 2007
Association of AGTR1 with 18-month treatment outcome in late-life depressionDouglas G Kondo, Marcy C Speer, K Ranga Krishnan, et al.
Journal of Psychopharmacology (Oxford, England)|November 4, 2011
Efficacy, safety, and tolerability of a triple reuptake inhibitor GSK372475 in the treatment of patients with major depressive disorder: two randomized, placebo- and active-controlled clinical trialsSusan Learned, Ole Graff, Suraja Roychowdhury, et al.
Pageof 3